This statement is further supported by findings demonstrating a crosstalk existing between the overactivated PI3K–Akt pathway and MAPK pathway in resistant melanoma responsible for the fine regulation of these pathways, including cross-inhibition mechanisms [15,23], that may be central for cellular responses to proliferative and survival stimuli [24] (Figure 8). The gene discussed is PIK3CG; the disease is melanoma.